Efficacy of lactoferrin in preventing recurrent urinary tract infections in pregnant Egyptian women: a randomized controlled trial.

ABSTRACT:

Background

Prevention of a very prevalent problem such as urinary tract infections (UTIs), is of utmost importance, particularly during pregnancy, in order to limit the irrational use of antibiotics. Lactoferrin (Lf) has proven in vivo and in vitro antibacterial actions, especially against Escherichia coli, which is the main causative organism of UTIs. The study question is, "Does the administration of Lf to pregnant women with a history of RUTIs reduce the incidence of new episodes of UTIs during pregnancy?".

Methods

This was a randomized controlled study over 6 months that started from February 2024 to August 2024, conducted at the antenatal clinic of El-Shatby University Hospital, Alexandria, Egypt. The study included 220 pregnant women (14-24 weeks' gestation) who had ex

SUBMITTER: Shoukry A 

PROVIDER: S-EPMC12016170 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature